Skip to main content
Equibles

Eric Weisblum

Board Member

Silo Pharma, Inc. (SILO)

CEO

Silo Pharma, Inc. (SILO)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Eric Weisblum

Eric Weisblum is recorded as Board Member and CEO at Silo Pharma, Inc. (SILO). Silo Pharma, Inc. reported in an 8-K filed September 30, 2022 that Eric Weisblum resigned as Chief Financial Officer, effective September 27, 2022. The proxy statement of Silo Pharma, Inc. reports total compensation of $521,750 for Eric Weisblum in fiscal 2025, including a base salary of $350,000. Disclosed compensation is on record for 4 fiscal years.

“On September 27, 2022, Eric Weisblum resigned as our Chief Financial Officer.”
Silo Pharma, Inc. Form 8-K, filed September 30, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Silo Pharma, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Silo Pharma, Inc. (SILO) $350,000 $521,750
2024 Silo Pharma, Inc. (SILO) $350,000 $630,051
2023 Silo Pharma, Inc. (SILO) $350,151 $569,009
2022 Silo Pharma, Inc. (SILO) $222,500 $332,250

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.